Efficacy and safety of zoledronic acid in the treatment of bone metastases associated with lung cancer and other solid tumors

被引:23
作者
Rosen, LS [1 ]
机构
[1] Canc Inst Med Grp, Dev Therapeut, Santa Monica, CA 90404 USA
关键词
D O I
10.1053/sonc.2002.37416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:28 / 32
页数:5
相关论文
共 53 条
[1]   DICHLOROMETHYLENE-DIPHOSPHONATE IN PATIENTS WITH PROSTATIC-CARCINOMA METASTATIC TO THE SKELETON [J].
ADAMI, S ;
SALVAGNO, G ;
GUARRERA, G ;
BIANCHI, G ;
DORIZZI, R ;
ROSINI, S ;
MOBILIO, G ;
LOCASCIO, V .
JOURNAL OF UROLOGY, 1985, 134 (06) :1152-1154
[2]  
Adami S, 1989, Recent Results Cancer Res, V116, P67
[3]  
Berenson JR, 2001, CANCER, V91, P1191, DOI 10.1002/1097-0142(20010401)91:7<1191::AID-CNCR1119>3.0.CO
[4]  
2-0
[5]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[6]   Current use of bisphosphonates in oncology [J].
Body, JJ ;
Bartl, R ;
Burckhardt, P ;
Delmas, PD ;
Diel, IJ ;
Fleisch, H ;
Kanis, JA ;
Kyle, RA ;
Mundy, GR ;
Paterson, AHG ;
Rubens, RD .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) :3890-3899
[7]  
Boissier S, 2000, CANCER RES, V60, P2949
[8]   Should bisphosphonates be the treatment of choice for metastatic bone disease? [J].
Coleman, RE .
SEMINARS IN ONCOLOGY, 2001, 28 (04) :35-41
[9]  
Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.3.CO
[10]  
2-Z